Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer

dc.contributor.author	Constenla Figueiras, Manuel
dc.date.accessioned	2017-06-07T07:03:34Z
dc.date.available	2017-06-07T07:03:34Z
dc.date.issued	2013
dc.identifier.issn	1699-048X
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2126
dc.language.iso	eng
dc.title	Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer
dc.type	Artigo	es
dc.authorsophos	Carrato, A.
dc.authorsophos	Gómez, A.
dc.authorsophos	Escudero, P.
dc.authorsophos	Chaves, M.
dc.authorsophos	Rivera, F.
dc.authorsophos	Marcuello, E.
dc.authorsophos	González, E.
dc.authorsophos	Grávalos, C.
dc.authorsophos	Constenla, M.
dc.authorsophos	Manzano, J. L.
dc.authorsophos	Losa, F.
dc.authorsophos	Maurel, J.
dc.authorsophos	Dueñas, R.
dc.authorsophos	Massuti, B.
dc.authorsophos	Gallego, J.
dc.authorsophos	Aparicio, J.
dc.authorsophos	Antón, A.
dc.authorsophos	Aranda, E.
dc.identifier.doi	10.1007/s12094-012-0993-x
dc.identifier.isi	323639200005
dc.identifier.pmid	23359181
dc.identifier.sophos	12628
dc.issue.number	9
dc.journal.title	Clinical & Translational Oncology
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Pontevedra e O Salnés - Complexo Hospitalario Universitario de Pontevedra::Oncoloxía médica
dc.page.initial	705
dc.page.final	711
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	15

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.